GRP
CGTX icon

Global Retirement Partners’s Cognition Therapeutics CGTX Stock Holding History

Global Retirement Partners’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.7K Hold
2,000
– – ﹤0.01% 3637
2025
Q3 		$2.7K Buy
+2,000
New +$2.73K ﹤0.01% 3211

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Global Retirement Partners's CGTX Position: Q4 2025 in Review

Global Retirement Partners held its Cognition Therapeutics (CGTX) position steady in Q4 2025 at 2,000 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3637.

Global Retirement Partners first reported a position in CGTX in Q3 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold CGTX as of Q4 2025.

  • Global Retirement Partners held 2,000 shares of Cognition Therapeutics worth $2.7K as of Q4 2025.
  • Global Retirement Partners left its Cognition Therapeutics share count unchanged in Q4 2025.
  • Cognition Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3637 holding.
  • Global Retirement Partners first reported a position in Cognition Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.